| Server IP : 51.83.223.64 / Your IP : 216.73.217.174 Web Server : Apache/2 System : Linux s104.addhost.pl 4.18.0-553.121.1.lve.el8.x86_64 #1 SMP Thu Apr 30 16:40:41 UTC 2026 x86_64 User : schlebek ( 1218) PHP Version : 7.3.33 Disable Function : exec,system,passthru,shell_exec,proc_close,proc_open,dl,popen,show_source,posix_kill,posix_mkfifo,posix_getpwuid,posix_setpgid,posix_setsid,posix_setuid,posix_setgid,posix_seteuid,posix_setegid,posix_uname MySQL : OFF | cURL : ON | WGET : OFF | Perl : OFF | Python : OFF | Sudo : OFF | Pkexec : OFF Directory : /home/schlebek/Maildir/new/ |
Upload File : |
Return-Path: <>
Delivered-To: schlebek@fryzjerbemowo.pl
Received: from s104.addhost.pl
by s104.addhost.pl with LMTP
id 6bBjAxK8R2oV5gsAgPQBPw
(envelope-from <>)
for <schlebek@fryzjerbemowo.pl>; Fri, 03 Jul 2026 15:41:38 +0200
Return-path: <>
Envelope-to: schlebek@fryzjerbemowo.pl
Delivery-date: Fri, 03 Jul 2026 15:41:38 +0200
Received: from mail by s104.addhost.pl with local (Exim 4.99.2)
id 1wfe9B-00000003Toq-3v5M
for schlebek@fryzjerbemowo.pl;
Fri, 03 Jul 2026 15:41:37 +0200
X-Failed-Recipients: kontakt@fryzjerbemowo.pl
Auto-Submitted: auto-replied
From: Mail Delivery System <Mailer-Daemon@s104.addhost.pl>
To: schlebek@fryzjerbemowo.pl
References: <XkqOiHCvBYEGcsfd2Run8H9AUGPC21AhETGF9HlouU@fryzjerbemowo.pl>
Content-Type: multipart/report; report-type=delivery-status; boundary=1783086097-eximdsn-1974917284
MIME-Version: 1.0
Subject: Mail delivery failed: returning message to sender
Message-Id: <E1wfe9B-00000003Toq-3v5M@s104.addhost.pl>
Date: Fri, 03 Jul 2026 15:41:37 +0200
--1783086097-eximdsn-1974917284
Content-type: text/plain; charset=us-ascii
This message was created automatically by mail delivery software.
A message that you sent could not be delivered to one or more of its
recipients. This is a permanent error. The following address(es) failed:
kontakt@fryzjerbemowo.pl
--1783086097-eximdsn-1974917284
Content-type: message/delivery-status
Reporting-MTA: dns; s104.addhost.pl
Action: failed
Final-Recipient: rfc822;kontakt@fryzjerbemowo.pl
Status: 5.0.0
--1783086097-eximdsn-1974917284
Content-type: message/rfc822
Return-path: <schlebek@fryzjerbemowo.pl>
Received: from schlebek by s104.addhost.pl with local (Exim 4.99.2)
(envelope-from <schlebek@fryzjerbemowo.pl>)
id 1wfe9B-00000003Tog-3GPB
for kontakt@fryzjerbemowo.pl;
Fri, 03 Jul 2026 15:41:37 +0200
To: kontakt@fryzjerbemowo.pl
Subject: Curly "[your-subject]"
Date: Fri, 3 Jul 2026 13:41:37 +0000
From: Roy Smith <kontakt@fryzjerbemowo.pl>
Reply-To: heinrichgunter50@gmail.com
Message-ID: <XkqOiHCvBYEGcsfd2Run8H9AUGPC21AhETGF9HlouU@fryzjerbemowo.pl>
X-Mailer: PHPMailer 7.0.0 (https://github.com/PHPMailer/PHPMailer)
MIME-Version: 1.0
Content-Type: text/plain; charset=UTF-8
From: Roy Smith <[your-email]>
Subject: [your-subject]
Message Body:
My name is Roy Smith, I am a research head with Hamilton Laboratory UK known for vast manufacturing.
I am reaching out to discuss a promising business opportunity that could be highly advantageous for both of us. I need a dependable foreign business partner to assist me in procuring a rare Premium Herbal Extract known as Kolmogorovian HG57.
Although this may not fall within your usual area of expertise, it presents an opportunity for an additional revenue stream for you or your organization. The limited availability of this raw material has impeded product development at my company. Our previous supplier in Ukraine has ceased operations due to the ongoing conflict in the region.
PROPOSAL: I am requesting your agreement to act as a new contractor between the manufacturer and Hamilton Laboratory to facilitate this project/contract.
We would share the profits from this venture, with 80% allocated to you and 20% to me. I am unable to bid for the supply contract myself, as I prefer to avoid direct contact between my company and the manufacturer, which also falls outside the scope of my employment contract.
Please respond to this email roy.smith@hamiltonpharmaceuticals.com so that I can provide you with further details regarding the process.
I look forward to establishing a mutually beneficial partnership.
Kind regards,
Roy Smith.
Research & Development Department
Durham Pharmaceuticals Limited
roy.smith@hamiltonpharmaceuticals.com
https://hamiltonpharmaceuticals.com
--1783086097-eximdsn-1974917284--